Effect of protein kinase inhibitors on primary antibody induction in tissue cultures

J Sterzl1, J Milerová, J Votruba

  • 1Inst. of Microbiology, Department of Immunology and Gnotobiology, Academy of Sciences of the Czech Republic, Prague. immuno@biomed.cas.cz

Insights

Protein-kinase-inhibitors (PKIs) demonstrated immunosuppressive action on antibody formation. Certain PKIs, including herbimycin A, sanguinarin, H-9, and wortmannin, showed the highest inhibitory effects in vitro.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Protein-kinase-inhibitors (PKIs) are crucial in cellular signaling pathways.
  • Protein kinases, including protein kinase C (PKC), phosphatidyl inositol 3-kinase (PI3-K), and protein tyrosine kinases (PTKs), play vital roles in immune responses.
  • The impact of PKIs on the early stages of antibody formation (Ab-response) requires further elucidation.

Purpose of the Study:

  • To investigate the in vitro effects of various PKIs on the induction phase of the primary antibody response.
  • To identify specific PKIs with significant inhibitory activity on antibody formation.

Main Methods:

  • In vitro testing of multiple protein-kinase-inhibitors (PKIs) including staurosporin, calphostin C, H-7, H-8, H-9 (PKCs), wortmannin (PI3-K), and genistein, herbimycin A, sanguinarin, lavendustin A, and B (PTKs).
  • Assessment of the inhibitory effects of these PKIs on the inductive phase of the primary antibody (Ab) response.

Main Results:

  • The study identified herbimycin A, sanguinarin, H-9, and wortmannin as PKIs exhibiting the highest inhibitory action on the primary Ab-response in vitro.
  • While wortmannin's effect on T-lymphocytes is known, this study highlights its role in suppressing antibody formation.

Conclusions:

  • This research provides the first report on the immunosuppressive action of protein-kinase-inhibitors (PKIs) on the inductive steps of antibody formation.
  • Specific PKIs demonstrate potent inhibitory effects on early B-cell activation and differentiation, suggesting potential therapeutic applications in controlling antibody-mediated immune responses.